Comparison of Contrast Agents in Liver Magnetic Resonance (MR) for the Detection of Hepatic Metastases
- Status
- TERMINATED
- Phase
- PHASE4
Clinical Trials Related to Colorectal Cancer
Related studies linked through entity extraction aliases.
Anlotinib Plus Penpulimab (AK105) for Chemo-refractory Metastatic Colorectal Cancer:ALTER-C003
- Status
- UNKNOWN
- Phase
- PHASE2
Late Organ Specific Adverse Effects hiPec or pElvic eXenteration
- Status
- UNKNOWN
- Phase
- N/A
Home To Stay: a Randomized Trial Evaluating a Post-discharge Mobile App for Elective Colorectal Surgery
- Status
- COMPLETED
- Phase
- NA
Polyprev: Study to Compare Fecal Immunochemical Test With Endoscopic Surveillance After Advanced Adenoma Resection in Fecal Immunochemical Test Colorectal Cancer Screening Programs.
- Status
- RECRUITING
- Phase
- NA
Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Modifications in Retinal Microvascularization With Targeted Anti-angiogenic Therapy in Colorectal Cancer
- Status
- RECRUITING
- Phase
- NA
Fecal Metagenomics and Metabolomics Analyses to Identify Potential Screening Biomarkers for Colorectal Polyps and Cancer in Chinese Population
- Status
- UNKNOWN
- Phase
- N/A
Myeloid-derived Suppressor Cells in Colorectal Cancer
- Status
- COMPLETED
- Phase
- N/A
ColoRectal Cancer Screening for Southern California Community Health Centers
- Status
- COMPLETED
- Phase
- PHASE3
Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Quality of Life and Survival of Patients With Colorectal Cancer 5 Years After Surgery - Follow-up of the RCT DIQOL
- Status
- COMPLETED
- Phase
- N/A
Changes of Muramyl Dipeptide in Intestinal and Extra-intestinal Diseases
- Status
- UNKNOWN
- Phase
- N/A
Exercise Preconditioning with Cancer Surgeries
- Status
- TERMINATED
- Phase
- NA
Veteran Primers for CRC Screening
- Status
- COMPLETED
- Phase
- NA
Relapse Markers for Colorectal Cancer
- Status
- COMPLETED
- Phase
- N/A
Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas
- Status
- RECRUITING
- Phase
- PHASE1
CTC vs Radiography as the Evidence of Recurrence in Colorectal Cancer Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Combination Therapy of RMC-4630 and LY3214996 in Metastatic KRAS Mutant Cancers
- Status
- TERMINATED
- Phase
- PHASE1
Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2